Skip to content

A single-center clinical study evaluating the performance of the Respiration Pathogen ID/AMR Panel (RPIP) for pathogenic diagnosis and drug resistance detection in HIV patients

A single-center clinical study evaluating the performance of the Respiration Pathogen ID/AMR Panel (RPIP) for pathogenic diagnosis and drug resistance detection in HIV patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071326
Enrollment
Unknown
Registered
2023-05-11
Start date
2023-05-15
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV with pulmonary infections

Interventions

Gold Standard:Detection of pathogenic microorganisms: clinical composite standard as a reference standard Resistance: Phenotypic susceptibility as reference standard
Index test:Illumina Respiration Pathogen ID/AMR Panel (RPIP)

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age=18 years,HIV+ (HIV Combo test+ or PCR+, then with a positive confirmatory test by CDC)with suspicious pulmonary infections, bronchoscopy and collection of BALF specimens are required based on clinical judgment. Suspected criteria need to include: • Imaging findings, new infiltration, consolidation, ground glass-like changes on chest X-ray or CT, with or without pleural effusion • With at least one of the following clinical signs/symptoms/testing results: o New-onset cough or worsening of existing respiratory symptoms, with or without purulent sputum, chest pain, dyspnea, or hemoptysis o Body temperature >38? or 10×10ˆ9/L or < 4×10ˆ9/L; elevated CRP or PCT, etc. Specially screened bacteria-positive patients should meet: • Patients who are clinically judged to require bronchoscopy and sputum specimens are also available • Positive Xpert® MTB/RIF test for Mycobacterium tuberculosis

Exclusion criteria

Exclusion criteria: • Patients with contraindications to bronchoscopy • Pregnant woman • The patient or legal representative refuses or cannot understand the consent form • Other conditions that investigator need to exclude

Design outcomes

Primary

MeasureTime frame
Agreement rate with reference standard;sensitivity;specificity;Positive predictive value;Negative predictive value;95% exact confidence interval;

Countries

China

Contacts

Public ContactWei Feili

Beijing Youan Hospital, Capital Medical University

Wflcn@126.com+86 13619265213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026